Regulation of B Lymphocyte Survival and Differentiation by HSH2
Regulation of B Lymphocyte Survival and Differentiation by HSH2
批准号:
7775050
负责人:
LOUIS B JUSTEMENT
金额:
$31.69万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-03-05 至 2012-02-29
关键词:
Adaptor Signaling ProteinAntigen ReceptorsApoptosisApoptoticAttenuatedAutoimmunityB-Cell DevelopmentB-LymphocytesBindingBiochemicalBone MarrowCD4 Positive T LymphocytesCell LineCell SurvivalCell physiologyCellsCellular biologyCessation of lifeDNADevelopmentDisease ProgressionDoctor of PhilosophyEffector CellEquilibriumEtiologyEventExhibitsFamilyFlow CytometryGene TargetingGoalsHematopoieticHomeostasisHourImmunofluorescence ImmunologicInterleukin-4IonomycinLaboratoriesLeadLifeLigationLinkLymphocyteLymphocyte BiologyMalignant NeoplasmsMediatingMembraneMitochondriaMolecularMusNatureOuter Mitochondrial MembranePathway interactionsPeripheralPeritoneumPhysiologicalPlayPopulationProteinsRegulationRegulatory PathwayResearch PersonnelRoleSignal TransductionSpleenSrc homology 2 domain-containing, transforming protein 1Staining methodStainsStimulusStructureT-LymphocyteTNFRSF5 geneTNFSF5 geneThymus GlandTissue StainsTransgenesUp-RegulationWestern Blottinganti-IgMcomputerized data processingimmune functioninsightknock-downloss of functionmacrophagenovelpopulation basedprogramsprotein expressionprotein functionreceptorresearch studyresponseretroviral-mediatedsmall hairpin RNAthymocyte
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The goal of this application is to elucidate the physiological role of the novel adaptor protein HSH2 (Hematopoietic SH2 protein) in regulation of B lymphocyte biology. Studies conducted in our laboratory have demonstrated that HSH2 is expressed at low basal levels in splenic B cells and that its expression is induced in response to stimuli that bind to distinct families of receptors that promote survival and differentiation, including CD40L, IL-4, LPS, CpG DMA and BLyS (BAFF). Up-regulation of HSH2 expression was shown to be dependent on activation of NF-?B and correlates with initiation of a survival response that includes up-.regulation of Bcl-XL. Retroviral-mediated expression of HSH2 in the WEHI-231 B cell line, which undergoes apoptosis in response to BCR ligation, was observed to enhance survival and mitochondrial stability. Similarly, enhanced survival of WEHI-231 cells in response to CD40-mediated signaling directly correlated with up-regulation of HSH2 expression. Although HSH2 does not significantly alter BCR-proximal signal transduction, it was observed to maintain mitochondrial stability and this correlated with its ability to block up-regulation of Bim in response to BCR signaling. Moreover, HSH2 was found to interact with the anti-apoptotic protein HAX-1, which possesses a membrane-spanning region that targets it to the outer mitochondrial membrane. Preliminary studies have shown that the interaction between HSH2 and HAX-1 is important for the anti-apoptotic activity of HSH2. Therefore, HSH2 and HAX-1 may function together to regulate mitochondrial integrity and cell survival. To further elucidate the physiological role of HSH2 in regulation of B lymphocyte survival/differentiation, three specific aims have been proposed that will: 1) determine the physiological role of HSH2 in B lymphocyte development, homeostasis and immune function; 2) elucidate the role that HSH2 plays in regulating Bim expression in response to co-stimulation; and 3) determine the functional importance of the interaction between HSH2 and HAX-1 in regulating mitochondrial stability. Because HSH2 expression is induced in response to many of the key stimuli that are known to promote B cell survival and differentiation, this adaptor protein is likely to play an important role in regulating B cell homeostasis and immune function. Therefore, these studies will provide novel insight into the molecular mechanisms that maintain the balance between B lymphocyte survival and death leading to differentiation into humoral effector cells and will provide insight into the etiology and progression of diseases associated with aberrant B cell function, including cancer and autoimmunity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identification and Analysis of the Physiological Ligand for TLT2
-
批准号:8568235
-
项目类别:
-
资助金额:$20.7万
-
财政年份:2013
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
CD19 Tyrosine-mediated Signal Transduction in vivo
-
批准号:8081969
-
项目类别:
-
资助金额:$9.99万
-
财政年份:2010
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
Regulation of B Lymphocyte Survival and Differentiation by HSH2
-
批准号:7612425
-
项目类别:
-
资助金额:$6.71万
-
财政年份:2008
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
Regulation of B Lymphocyte Survival and Differentiation by HSH2
-
批准号:7191849
-
项目类别:
-
资助金额:$32.63万
-
财政年份:2007
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
Regulation of B Lymphocyte Survival and Differentiation by HSH2
-
批准号:7367189
-
项目类别:
-
资助金额:$32.01万
-
财政年份:2007
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
Regulation of B Lymphocyte Survival and Differentiation by HSH2
-
批准号:8030421
-
项目类别:
-
资助金额:$31.37万
-
财政年份:2007
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
Regulation of B Lymphocyte Survival and Differentiation by HSH2
-
批准号:7586201
-
项目类别:
-
资助金额:$32.01万
-
财政年份:2007
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
CD19 Tyrosine-mediated Signal Transduction in vivo
-
批准号:7647892
-
项目类别:
-
资助金额:$36.25万
-
财政年份:1998
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
CD19 Tyrosine-mediated Signal Transduction in vivo
-
批准号:7533208
-
项目类别:
-
资助金额:$36.25万
-
财政年份:1998
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
CD19 Tyrosine-mediated Signal Transduction in vivo
-
批准号:8289609
-
项目类别:
-
资助金额:$35.53万
-
财政年份:1998
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
CD19 Tyrosine-mediated Signal Transduction in vivo
-
批准号:8079028
-
项目类别:
-
资助金额:$35.53万
-
财政年份:1998
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
CD19 Tyrosine-mediated Signal Transduction in vivo
-
批准号:7880585
-
项目类别:
-
资助金额:$35.89万
-
财政年份:1998
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
MOLECULAR MECHANISMS MEDIATING CD22 ACCESSORY FUNCTION
-
批准号:6631860
-
项目类别:
-
资助金额:$23.46万
-
财政年份:1995
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
MOLECULAR MECHANISMS MEDIATING CD22 ACCESSORY FUNCTION
-
批准号:2376381
-
项目类别:
-
资助金额:$15.58万
-
财政年份:1995
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
MOLECULAR MECHANISMS MEDIATING CD22 ACCESSORY FUNCTION
-
批准号:2849455
-
项目类别:
-
资助金额:$19.37万
-
财政年份:1995
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
MOLECULAR MECHANISMS MEDIATING CD22 ACCESSORY FUNCTION
-
批准号:6373408
-
项目类别:
-
资助金额:$21.73万
-
财政年份:1995
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
MOLECULAR MECHANISMS MEDIATING CD22 ACCESSORY FUNCTION
-
批准号:6169791
-
项目类别:
-
资助金额:$20.21万
-
财政年份:1995
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
MOLECULAR MECHANISMS MEDIATING CD22 ACCESSORY FUNCTION
-
批准号:6510549
-
项目类别:
-
资助金额:$22.77万
-
财政年份:1995
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
MOLECULAR MECHANISMS MEDIATING CD22 ACCESSORY FUNCTION
-
批准号:2667746
-
项目类别:
-
资助金额:$16.2万
-
财政年份:1995
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
MOLECULAR MECHANISMS MEDIATING CD22 ACCESSORY FUNCTION
-
批准号:2072678
-
项目类别:
-
资助金额:$15.31万
-
财政年份:1995
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
海外基金